D. Kandzari

发表

D. Kandzari, J. Tcheng, 2003, American heart journal.

Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

P. Serruys, G. Stone, A. Kastrati, 2019, Circulation. Cardiovascular interventions.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

S. Windecker, J. Massaro, L. Mauri, 2015, JAMA.

Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2014, The New England journal of medicine.

Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter.

R. Schmieder, S. Bertog, D. Kandzari, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry

Deepak L. Bhatt, K. Kario, G. Mancia, 2016, European heart journal.

Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial

Deepak L. Bhatt, Murray Esler, S. Oparil, 2012, Clinical cardiology.

The Outcomes of Percutaneous revascularizaTIon for Management of sUrgically ineligible patients with Multivessel or left main coronary artery disease (OPTIMUM) registry: Rationale and design.

J. Spertus, Z. Ali, D. Kandzari, 2022, Cardiovascular revascularization medicine : including molecular interventions.

A clinical approach and comprehensive review of percutaneous revascularization of coronary chronic total occlusion

D. Kandzari, D. Mukherjee, S. Kar, 2017 .

Treatment of chronic total coronary occlusions with drug‐eluting stents

D. Kandzari, 2013 .

Drug-eluting stents for chronic total occlusions: the North American and Asian experience

D. Kandzari, 2007 .

Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

P. Serruys, G. Stone, A. Kastrati, 2017 .

Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

J. J. Griffin, G. Stone, C. Grines, 2003, Circulation.

Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.

P. Teirstein, M. Price, D. Kandzari, 2009, JACC. Cardiovascular interventions.

Renal denervation therapy for hypertension: pathways for moving development forward.

R. Virmani, W. White, R. Townsend, 2015, Journal of the American Society of Hypertension : JASH.

The ROX coupler: Creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature

Ajay K. Jain, D. Kandzari, P. Sobotka, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right

A. Kirtane, M. Leon, R. Townsend, 2015, Journal of clinical hypertension.

Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.

R. Whitbourn, M. Böhm, D. Kandzari, 2015, Journal of the American College of Cardiology.

Percutaneous Treatment of Coronary Chronic Total Occlusions Part 1: Rationale and Outcomes.

E. Brilakis, I. Moussa, D. Kandzari, 2014, Interventional cardiology.

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2014, Journal of the American College of Cardiology.

Chronic Total Occlusions: Practice Makes Perfect-Implications for Standardizing Performance and Training.

P. Kaul, D. Kandzari, 2020, Circulation. Cardiovascular interventions.

Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.

P. Serruys, G. Stone, F. Horkay, 2018, JACC. Cardiovascular interventions.

Treatment of the chronic total occlusion: A call to action for the interventional community

Craig A. Thompson, E. Brilakis, J. Spratt, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous coronary intervention of unprotected left main coronary artery disease

P. Teirstein, G. Stone, Seung‐Jung Park, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.

P. Fitzgerald, M. Leon, D. Kandzari, 2007, The American journal of cardiology.

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

R. Virmani, G. Stone, A. Finn, 2021, Circulation.

Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting.

J. Jollis, D. Kandzari, J. Zidar, 2006, The American journal of cardiology.

A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction.

C. Grines, D. Kandzari, D. Erlinge, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction.

B. Gersh, G. Stone, C. Grines, 2005, European heart journal.

Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction.

B. Gersh, G. Stone, C. Grines, 2005, European Heart Journal.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

Can't Bare It Any Longer.

D. Kandzari, 2016, JACC. Cardiovascular interventions.

Stent selection and antiplatelet therapy duration: one size does not fit all.

D. Kandzari, 2015, Journal of the American College of Cardiology.

Use of drug‐eluting stents for chronic total occlusions: A systematic review and meta‐analysis

B. Rangan, Subhash Banerjee, E. Brilakis, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry.

Craig A. Thompson, S. Garcia, A. Kirtane, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease

S. Pocock, P. Serruys, G. Stone, 2020 .

Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial.

S. Pocock, P. Serruys, G. Stone, 2020, JACC. Cardiovascular interventions.

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial

P. Serruys, G. Stone, D. Kandzari, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ridaforolimus eluting stent for the treatment of Japanese patients with coronary disease: 1 year outcomes of the JNIR study

S. Saito, G. Perlman, D. Kandzari, 2020, Cardiovascular Intervention and Therapeutics.

Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study).

D. Kandzari, I. Meredith, D. Allocco, 2019, The American journal of cardiology.

The Day After a Primary Endpoint.

D. Kandzari, 2018, JACC. Cardiovascular interventions.

Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).

E. Edelman, G. Stone, A. Íñiguez, 2017, Circulation.

Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration

P. Serruys, G. Stone, A. Kastrati, 2017, JAMA cardiology.

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.

P. Serruys, G. Stone, A. Kastrati, 2016, JACC. Cardiovascular interventions.

One-Year Outcomes in "Real-World" Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS]).

D. Kandzari, T. Christen, K. Dawkins, 2016, The American journal of cardiology.

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization

P. Serruys, G. Stone, A. Kastrati, 2016 .

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

K. Kario, R. Townsend, R. Schmieder, 2022, The Lancet.

Meta-analysis of the effect of renal denervation on blood pressure and pulse pressure in patients with resistant systemic hypertension.

D. Kandzari, P. Sobotka, S. Pancholy, 2014, The American journal of cardiology.

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

P. Whelton, G. Stone, G. Parati, 2022, Circulation.

Changes in Plasma Renin Activity after Renal Artery Sympathetic Denervation.

S. Pocock, K. Kario, M. Böhm, 2021, Journal of the American College of Cardiology.

Confounding Factors in Renal Denervation Trials: Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension.

Deepak L. Bhatt, K. Kario, M. Böhm, 2020, Hypertension.

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design

S. Pocock, K. Kario, M. Böhm, 2020, Clinical Research in Cardiology.

Renal denervation for hypertension: what is needed, and what is next.

D. Kandzari, 2019, European heart journal.

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.

K. Kario, M. Böhm, R. Townsend, 2019, JACC. Cardiovascular interventions.

Renal denervation for the treatment of hypertension: Making a new start, getting it right

A. Kirtane, M. Leon, R. Townsend, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right

A. Kirtane, M. Leon, R. Townsend, 2015, Clinical cardiology.

Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions.

Craig A. Thompson, S. Garcia, E. Mahmud, 2017, The American journal of cardiology.

Effect of Lesion Age on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary US Multicenter Registry.

Craig A. Thompson, S. Garcia, A. Kirtane, 2016, The Canadian journal of cardiology.

Elective Intervention for Stable Angina or Silent Ischemia

D. Kandzari, G. Barsness, 2012 .

Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial

S. Pocock, M. Böhm, R. Townsend, 2019, European heart journal.

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.

V. Hasselblad, R. Califf, G. Stone, 2004, American heart journal.

The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.

Si‐Hyuck Kang, D. Kandzari, K. Park, 2014, American heart journal.

Present and evolving role of eptifibatide in the treatment of acute coronary syndromes

L. Newby, R. Harrington, D. Kandzari, 2007, Expert review of cardiovascular therapy.

Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

P. Serruys, G. Stone, A. Kastrati, 2015, The American journal of cardiology.

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

P. Teirstein, M. Price, E. Topol, 2009, American heart journal.

Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention.

G. Stone, Seung‐Jung Park, G. Biondi-Zoccai, 2010, JACC: Cardiovascular Interventions.

Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction.

J. J. Griffin, J. Carroll, G. Stone, 2004, The American journal of cardiology.

Cost and mortality implications of lower event rates after implantation of an ultrathin strut coronary stent compared with a thin strut stent over four years.

D. Kandzari, S. Mattke, M. Hanson, 2019, Cardiovascular revascularization medicine : including molecular interventions.

A Controlled Trial of Renal Denervation for Resistant Hypertension

Deepak L. Bhatt, W. O’Neill, D. Kandzari, 2014 .

Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes

D. Kandzari, 2004, Current cardiology reports.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

S. Pocock, P. Serruys, G. Stone, 2019, The New England journal of medicine.

Timing of Stent Thrombosis After 1-Month Discontinuation of Dual Antiplatelet Therapy.

G. Stone, T. Nazif, S. Windecker, 2022, Journal of the American College of Cardiology.

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients

M. Price, G. Stone, A. Kirtane, 2020, Circulation. Cardiovascular interventions.

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.

M. Price, G. Stone, A. Kirtane, 2020, The New England journal of medicine.

ONE MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS: PRIMARY RESULTS FROM THE ONYX ONE CLEAR STUDY

M. Price, G. Stone, A. Kirtane, 2020 .

Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.

P. Serruys, G. Stone, A. Kastrati, 2016, JACC. Cardiovascular interventions.

Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial

P. Serruys, G. Stone, M. Leon, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry)

S. Garcia, E. Mahmud, A. Kirtane, 2019, Angiology.

Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry

A. Kirtane, F. Jaffer, Z. Ali, 2016, Circulation. Cardiovascular interventions.

APPLICATION AND OUTCOMES OF THE HYBRID APPROACH TO CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION: AN UPDATE FROM A CONTEMPORARY MULTICENTER U.S. REGISTRY

S. Garcia, E. Mahmud, A. Kirtane, 2016 .

Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).

S. Garcia, A. Kirtane, F. Jaffer, 2016, The American journal of cardiology.

Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: Insights from a multicenter united states registry

Subhash Banerjee, E. Brilakis, D. Kandzari, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The efficacy and safety of the "hybrid" approach to coronary chronic total occlusions: insights from a contemporary multicenter US registry and comparison with prior studies.

S. Garcia, A. Kotsia, B. Rangan, 2014, The Journal of invasive cardiology.

The efficacy of “hybrid” percutaneous coronary intervention in chronic total occlusions caused by in‐stent restenosis: Insights from a US multicenter registry

S. Garcia, A. Kotsia, B. Rangan, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A novel application of contrast echocardiography to exclude active coronary perforation bleeding in patients with pericardial effusion

D. Kandzari, S. Rinfret, D. Karmpaliotis, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Development of a high‐volume, multiple‐operator program for percutaneous chronic total coronary occlusion revascularization: procedural, clinical, and cost‐utilization outcomes

D. Kandzari, W. Lombardi, D. Karmpaliotis, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of prior coronary artery bypass graft surgery on chronic total occlusion revascularisation: insights from a multicentre US registry

Subhash Banerjee, E. Brilakis, D. Kandzari, 2013, Heart.

Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry).

Subhash Banerjee, E. Brilakis, D. Kandzari, 2013, The American journal of cardiology.

Percutaneous Chronic Total Occlusion Revascularization: Program Development, Resource Utilization, and Economic Outcomes.

E. Brilakis, D. Kandzari, D. Karmpaliotis, 2012, Interventional cardiology clinics.

Retrograde coronary chronic total occlusion revascularization: procedural and in-hospital outcomes from a multicenter registry in the United States.

Subhash Banerjee, E. Brilakis, D. Kandzari, 2012, JACC. Cardiovascular interventions.

A percutaneous treatment algorithm for crossing coronary chronic total occlusions.

E. Brilakis, C. Buller, D. Kandzari, 2012, JACC. Cardiovascular interventions.

Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents

P. Serruys, G. Stone, A. Kastrati, 2022 .

Stent Selection and Antiplatelet€Therapy€Duration

D. Kandzari, 2022 .

Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials

S. Saito, S. Windecker, D. Kandzari, 2022, Clinical Research in Cardiology.

Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study

M. Price, G. Stone, S. Windecker, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

S. Pocock, P. Serruys, G. Stone, 2018, Journal of the American College of Cardiology.

Correlates and Impact of Coronary Artery Calci ﬁ cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

P. Serruys, G. Stone, A. Kastrati, 2022 .

Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.

G. Stone, M. Leon, G. Perlman, 2018, JACC. Cardiovascular interventions.

Long‐term clinical outcomes in patients treated with drug‐eluting compared to bare‐metal stents for the treatment of transplant coronary artery disease

E. Mahmud, A. Kirtane, D. Kandzari, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical outcomes following predilation with a novel 1.25‐mm diameter angioplasty catheter

P. Teirstein, M. Price, Subhash Banerjee, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Cardiology, for what it's worth.

J. Jollis, D. Kandzari, 2000, American heart journal.

A clinical rationale and strategy for chronic total coronary occlusion revascularization: innovative solutions to an old problem

D. Kandzari, C. Barker, Colin M. Barker, 2010 .

Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients.

H. Suryapranata, D. Kandzari, M. de Boer, 2014, Atherosclerosis.

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy

K. Kario, A. Kirtane, M. Böhm, 2019, Hypertension.

Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial.

Manesh R. Patel, K. Kario, M. Böhm, 2018, Circulation.

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension

R. Schmieder, S. Bertog, D. Kandzari, 2021, Circulation. Cardiovascular interventions.

Left Main Disease: At the Intersection of Surgery and Stents.

J. Moses, D. Kandzari, 2017, JACC. Cardiovascular interventions.

Influence of Total Coronary Occlusion on Clinical Outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial).

Mauricio G. Cohen, D. Kandzari, M. Moscucci, 2016, The American journal of cardiology.

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy.

M. Price, G. Stone, A. Kirtane, 2019, American heart journal.

Late thrombosis following treatment of in‐stent restenosis with drug‐eluting stents after discontinuation of antiplatelet therapy

D. Kandzari, M. Sketch, H. Phillips, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention

R. Califf, D. Kandzari, 2002, Current opinion in cardiology.

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Deepak L. Bhatt, D. Kandzari, J. Davies, 2014, International journal of cardiology.

Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.

R. Whitbourn, R. Schmieder, D. Kandzari, 2013, Interventional cardiology.

Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.

W. Gibler, E. Ohman, E. Peterson, 2005, American heart journal.

Experience with glycoprotein IIb/IIIa antagonists in patients with acute coronary syndromes.

K. Mahaffey, D. Kandzari, 2002, Journal of interventional cardiology.

Quality of life with PCI versus medical therapy in stable coronary disease.

P. Teirstein, D. Kandzari, Ryan Brown, 2008, The New England journal of medicine.

Percutaneous Coronary Intervention in Perspective: Drug-Eluting Stents as a Model for Regulatory Review

A. Farb, D. Kandzari, A. Boam, 2009, Circulation. Cardiovascular interventions.

Aspirin dose and six-month outcome after an acute coronary syndrome.

Deepak L. Bhatt, R. Califf, E. Topol, 2004, Journal of the American College of Cardiology.

Aspirin , Non-Steroidal Anti-Inflammatories , and CAD spirin Dose and Six-Month utcome After an Acute Coronary Syndrome

R. Califf, D. Kandzari, N. Kleiman, 2004 .

Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction.

B. Gersh, G. Stone, C. Grines, 2006, American heart journal.

Aspirin Use Post-Acute Coronary Syndromes: Intolerance, Bleeding and Discontinuation

R. Califf, L. Newby, P. Armstrong, 2003, Journal of Thrombosis and Thrombolysis.

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials

V. Hasselblad, R. Califf, G. Stone, 2003 .

Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes.

D. Kandzari, Wei Li, Yang Wang, 2010, JACC. Cardiovascular interventions.

Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)

J. J. Griffin, J. Carroll, G. Stone, 2003 .

Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity.

P. Teirstein, M. Price, S. Murray, 2010, JACC. Cardiovascular interventions.

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2015, Journal of the American College of Cardiology.

Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes From the BIONICS and NIREUS Trials.

G. Stone, M. Leon, G. Perlman, 2020, JACC. Cardiovascular interventions.

Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft.

S. Garcia, E. Mahmud, A. Kirtane, 2020, JACC. Cardiovascular interventions.

Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.

S. Pocock, P. Serruys, G. Stone, 2020, Journal of the American College of Cardiology.

Outcomes of Patients With Coronary Arterial Bifurcation Narrowings Undergoing Provisional 1-Stent Treatment (from the BIONICS Trial).

G. Stone, G. Perlman, D. Kandzari, 2020, The American journal of cardiology.

Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.

P. Serruys, G. Stone, M. Leon, 2019, European heart journal.

Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry.

L. Stanberry, S. Garcia, E. Mahmud, 2019, JACC. Cardiovascular interventions.

Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention.

S. Garcia, E. Mahmud, A. Kirtane, 2020, International journal of cardiology.

Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry).

S. Garcia, E. Mahmud, A. Kirtane, 2019, The American journal of cardiology.

In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure.

S. Garcia, E. Mahmud, A. Kirtane, 2018, The American journal of cardiology.

The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.

S. Garcia, E. Mahmud, A. Kirtane, 2018, JACC. Cardiovascular interventions.

The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions.

Sunil V. Rao, Mauricio G. Cohen, D. Kandzari, 2010, Journal of the American College of Cardiology.

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease

B. Gersh, P. Serruys, G. Stone, 2018 .

Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.

P. Serruys, G. Stone, D. Kandzari, 2019, Circulation. Cardiovascular interventions.

Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.

Sunil V. Rao, J. Moses, B. Strauss, 2009, JACC: Cardiovascular Interventions.

Saphenous vein graft intervention.

G. Stone, Seung‐Jung Park, A. Kirtane, 2011, JACC. Cardiovascular interventions.

Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials.

P. Serruys, G. Stone, A. Kastrati, 2018, JACC. Cardiovascular interventions.

Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents.

M. Leon, L. Mauri, R. Mehran, 2011, JACC. Cardiovascular interventions.

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1â• ̄month of dual antiplatelet therapy

M. Price, G. Stone, R. Mehran, 2019 .

The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent.

A. Kirtane, M. Leon, L. Mauri, 2013, JACC. Cardiovascular interventions.

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.

Hyun-Jae Kang, Young-Bae Park, Si-Hyuck Kang, 2014, European heart journal.

Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).

J. Moses, A. Kini, D. Kandzari, 2015, JACC. Cardiovascular interventions.

Procedural effectiveness with a focused force scoring angioplasty catheter: Procedural and clinical outcomes from the Scoreflex NC trial.

Mauricio G. Cohen, D. Kandzari, Robert F. Riley, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Manesh R. Patel, Neha J. Pagidipati, J. Stehli, 2020, The Lancet.

Application of the "hybrid approach" to chronic total occlusions in patients with previous coronary artery bypass graft surgery (from a Contemporary Multicenter US registry).

S. Garcia, A. Kotsia, B. Rangan, 2014, The American journal of cardiology.

Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.

A. Kirtane, D. Kandzari, R. Cheng, 2012, The American journal of cardiology.

Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.

G. Stone, F. Jaffer, N. Bozinovic, 2019, Circulation.

Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score.

S. Garcia, F. Jaffer, J. Moses, 2016, JACC. Cardiovascular interventions.

Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.

S. Garcia, E. Mahmud, A. Kirtane, 2017, The American journal of cardiology.

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.

S. Steinhubl, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

R. Townsend, K. Ferdinand, D. Kandzari, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results

M. Price, G. Stone, A. Kirtane, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Coronary Stenting in Patients With Small Coronary Arteries at High Risk of Bleeding: Onyx ONE Clear

M. Price, G. Stone, T. Nazif, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

IMPACT OF FINAL MINIMAL STENT AREA BY IVUS ON 3-YEAR OUTCOME AFTER PCI OF LEFT MAIN CORONARY ARTERY DISEASE: THE EXCEL TRIAL

P. Serruys, G. Stone, F. Horkay, 2017 .

Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.

I. Goldstein, D. Kandzari, M. Jaff, 2012, Journal of the American College of Cardiology.

A novel technique for ultra‐low contrast administration during angiography or intervention

Keshav R. Nayak, P. Teirstein, M. Price, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

REPLY: ITT (intrepret and test to effectively treat) approach for no‐reflow

D. Kandzari, E. Navarese, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study

D. Kandzari, P. Gurbel, E. Navarese, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy-Reply.

Sunil V. Rao, D. Kandzari, R. Shah, 2019, JAMA cardiology.

Transradial versus transfemoral method of two-stent implantation for true bifurcation lesions: comparison of immediate and long-term outcomes.

D. Kandzari, B. Xu, Hongbing Yan, 2014, Journal of interventional cardiology.

Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.

V. Hasselblad, M. Carrier, J. Tardif, 2007, The Journal of thoracic and cardiovascular surgery.

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial.

P. Serruys, G. Stone, R. Stables, 2017, JACC. Cardiovascular interventions.

Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study

J. Spertus, Z. Qian, D. Kandzari, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease after

P. Serruys, G. Stone, D. Kandzari, 2017 .

Intracoronary brachytherapy: time to sell short?

D. Mark, D. Kandzari, 2002, Circulation.

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial.

P. Serruys, G. Stone, M. Leon, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention: Technique Analysis From the EXCEL Trial

P. Serruys, G. Stone, M. Leon, 2018, Circulation. Cardiovascular interventions.

Revascularization for Unprotected Left Main Coronary Artery Disease: An Evolution in Clinical Decision Making

D. Kandzari, J. Ormiston, 2011, Current cardiology reports.

Change we can believe in: the hyper-evolution of percutaneous coronary intervention for unprotected left main disease with drug-eluting stents.

P. Teirstein, M. Price, D. Kandzari, 2008, Circulation. Cardiovascular interventions.

Growth factor receptors, phospholipases, phospholipid kinases and actin reorganization.

D. Kandzari, P. Goldschmidt-Clermont, S. Gips, 1994, Seminars in cell biology.

One-year outcomes from the TAXUS express stent versus cypher stent.

W. O’Neill, D. Baim, D. Kandzari, 2009, The American journal of cardiology.

Sirolimus-Eluting Cypher Stent

D. Kandzari, C. Barker, Colin M. Barker, 2022 .

Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials

S. Saito, S. Windecker, D. Kandzari, 2022, Clinical Research in Cardiology.

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model

A. Finn, D. Kandzari, F. Mahfoud, 2022, Journal of hypertension.

Long‐term efficacy and safety of zotarolimus‐eluting stent in patients with diabetes mellitus: Pooled 5‐year results from the ENDEAVOR III and IV trials

M. Pencina, M. Leon, L. Mauri, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical Utility of the Japan–Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry

S. Garcia, F. Jaffer, Megan A Kypreos, 2015, Circulation. Cardiovascular interventions.

Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study

J. Moses, D. Kandzari, J. Popma, 2018, Coronary artery disease.

Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot – Authors' reply

D. Kandzari, M. Böhm, F. Mahfoud, 2022, The Lancet.

Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.

K. Kario, M. Böhm, R. Townsend, 2021, Journal of the American College of Cardiology.

Prioritized Endpoints for Device-Based Hypertension Trials: the Win Ratio Methodology.

S. Pocock, M. Böhm, M. Fahy, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Intracoronary Imaging and Stent Implantation Technique.

P. Kaul, D. Kandzari, 2018, Circulation. Cardiovascular interventions.

Entering a Polymer-Free Era.

D. Kandzari, Eric A. Secemsky, 2019, Circulation. Cardiovascular interventions.

Usefulness of the SYNTAX and clinical SYNTAX scores in predicting clinical outcome after unrestricted use of sirolimus- and everolimus-eluting Stents.

Si‐Hyuck Kang, D. Kandzari, Hae-Young Lee, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Coronary Occlusion During TAVR: If You Think About it, Protect it.

D. Kandzari, Pradeep K Yadav, 2020, JACC. Cardiovascular interventions.

Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry.

S. Garcia, A. Kirtane, F. Jaffer, 2016, International journal of cardiology.

Clinical experience of the PK Papyrus covered stent in patients with coronary artery perforations: Results from a multi-center humanitarian device exemption survey.

D. Kandzari, R. Waksman, R. Sarao, 2022, Cardiovascular revascularization medicine : including molecular interventions.

PK Papyrus covered stent: Device description and early experience for the treatment of coronary artery perforations

D. Kandzari, R. Birkemeyer, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study

F. Jaffer, E. Brilakis, D. Kandzari, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.

S. Garcia, A. Kirtane, F. Jaffer, 2015, International journal of cardiology.

Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.

G. Stone, J. Wójcik, F. Jaffer, 2021, Journal of the American College of Cardiology.

Mother-Daughter-Granddaughter Double GuideLiner Technique for Delivering Stents Past Multiple Extreme Angulations.

D. Kandzari, W. Nicholson, D. Karmpaliotis, 2016, Circulation. Cardiovascular interventions.

Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry.

S. Garcia, A. Kirtane, F. Jaffer, 2016, The Journal of invasive cardiology.

Mechanism of luminal gain with plaque excision in atherosclerotic coronary and peripheral arteries: assessment by histology and intravascular ultrasound.

A. Yeung, D. Kandzari, J. Simpson, 2007, Journal of interventional cardiology.

Incidence and predictors of target lesion failure in patients with lesions in small vessels undergoing PCI with contemporary drug-eluting stents: Insights from the BIONICS study.

G. Stone, G. Perlman, D. Kandzari, 2020, Cardiovascular Revascularization Medicine.

Late‐term safety and effectiveness of everolimus‐eluting stents in chronic total coronary occlusion revascularization: Final 4‐year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial

J. Moses, A. Kini, D. Kandzari, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The thrill is gone: Catheter‐based exclusion of a posttraumatic arteriovenous fistula with a covered stent graft

D. Kandzari, A. Halabi, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Manesh R. Patel, Timothy N Murphy, Deepak L. Bhatt, 2022, The Lancet.

Blood pressure lowering with alcohol‐mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location

M. Böhm, S. Bertog, D. Kandzari, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy

D. Kandzari, P. Gurbel, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Keshav R. Nayak, P. Teirstein, M. Price, 2009, The American journal of cardiology.

Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000.

D. Kandzari, Darren K Mcguire, C. Dyke, 2000, American heart journal.

Early Experience with the HeartMate Percutaneous Heart Pump from the SHIELD II Trial

Samin K. Sharma, V. Rajagopal, D. Kandzari, 2021, ASAIO journal.

The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention.

D. Kandzari, P. Goldschmidt-Clermont, H. Phillips, 2002, The Journal of invasive cardiology.

Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 Trials.

G. Stone, M. Leon, G. Mintz, 2021, JACC. Cardiovascular interventions.

Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women: Insights From the Pooled PLATINUM Diversity and PROMUS ELEMENT PLUS Postapproval Studies

R. Mehran, D. Kandzari, J. Chandrasekhar, 2019, Circulation. Cardiovascular interventions.

Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative.

P. Serruys, G. Stone, A. Kastrati, 2018, JACC. Cardiovascular interventions.

CORONARY Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization Results From the EXPERT CTO Multicenter Trial ( Evaluation of the XIENCE Coronary Stent , Performance , and Technique in Chronic Total Occlusions )

J. Moses, A. Kini, D. Kandzari, 2017 .

Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis

D. Kandzari, J. Warner, J. K. Harrison, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.

S. Stevens, Mauricio G. Cohen, J. Alexander, 2011, American heart journal.

Effect of Baseline Anemia on Outcomes After Left Main Coronary Revascularization.

P. Serruys, G. Stone, R. Mehran, 2020, Journal of the American College of Cardiology.

The end of ENDEAVOR IV: the stent comparison trial's final follow-up

A. Kirtane, D. Kandzari, S. Gunda, 2013, Expert review of cardiovascular therapy.

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial

R. Wilensky, K. Kario, R. Townsend, 2022, Clinical Research in Cardiology.

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent

S. Saito, D. Kandzari, J. Koolen, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

ong-Term Clinical and Economic Analysis of the ndeavor Zotarolimus-Eluting Stent Versus the ypher Sirolimus-Eluting Stent

K. Anstrom, M. Leon, D. Kandzari, 2022 .

Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry

S. Garcia, A. Kirtane, F. Jaffer, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Inadvertent Transarterial Lead Placement in the Left Ventricle and Aortic Cusp: Percutaneous Lead Removal with Carotid Embolic Protection and Stent Graft Placement

D. Kandzari, I. Kosmidou, D. Karmpaliotis, 2012, Indian pacing and electrophysiology journal.

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial

K. Kario, R. Townsend, R. Schmieder, 2022, Hypertension.

The challenges of chronic total coronary occlusions: an old problem in a new perspective.

D. Kandzari, 2004, Journal of interventional cardiology.

Procedural effectiveness of a novel 1.20 mm diameter angioplasty catheter: clinical and angiographic outcomes.

P. Teirstein, W. Cheong, D. Kandzari, 2013, Journal of interventional cardiology.

Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

P. Fitzgerald, P. Yock, M. Leon, 2009, JACC. Cardiovascular interventions.

Transradial approach for coronary chronic total occlusion interventions: Insights from a contemporary multicenter registry

S. Garcia, A. Kotsia, B. Rangan, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CTO PCI Procedural Planning.

D. Kandzari, D. Karmpaliotis, N. Lembo, 2012, Interventional cardiology clinics.

First-in-Man Experience With the ClearLumen Thrombectomy System as an Adjunctive Therapy in Primary Percutaneous Coronary Interventions.

J. Harnek, D. Kandzari, L. Biasco, 2016, Journal of interventional cardiology.

Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

D. Kandzari, P. Goldschmidt-Clermont, 1999, JAMA.

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis

H. Suryapranata, A. Finn, L. Mauri, 2013, BMJ.

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial

R. Wilensky, K. Kario, R. Townsend, 2022, Clinical Research in Cardiology.

Not all subintimal chronic total occlusion revascularization is alike.

D. Kandzari, W. Lombardi, J. Grantham, 2013, Journal of the American College of Cardiology.

Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory.

Andrew A. White, Keshav R. Nayak, D. Kandzari, 2009, The Journal of invasive cardiology.

CLINICAL RESEARCH Interventional Cardiology Influence of Treatment Duration With a 600-mg Dose of Clopidogrel Before Percutaneous Coronary Revascularization

S. Steinhubl, A. Kastrati, J. Mehilli, 2004 .

Inflammation, platelets, and glycoprotein IIb/IIIa inhibitors.

D. Kandzari, P. Goldschmidt-Clermont, M. Sketch, 2002, The Journal of invasive cardiology.

Use of the Limited Antegrade Subintimal Tracking Technique in Chronic Total Occlusion Percutaneous Coronary Intervention.

F. Jaffer, B. Rangan, E. Brilakis, 2022, JACC. Cardiovascular interventions.

Procedural and Clinical Outcomes with Catheter-Based Plaque Excision in Critical Limb Ischemia

C. Walker, D. Kandzari, R. Gammon, 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.

Deepak L. Bhatt, K. Kario, G. Mancia, 2016, European heart journal.

Import and export of interventional technique: something to declare at the border.

D. Kandzari, 2009, JACC. Cardiovascular interventions.

Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry.

S. Garcia, A. Kirtane, F. Jaffer, 2017, The Canadian journal of cardiology.

Bioresorbable polymer drug-eluting stents – Authors' reply

L. Mauri, D. Kandzari, R. Waksman, 2018, The Lancet.

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial

K. Kario, R. Townsend, R. Schmieder, 2022, Hypertension Research.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Braunwald, S. Normand, E. Braunwald, 2014, The New England journal of medicine.

Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

M. Leon, M. Valgimigli, A. Lansky, 2021, European heart journal.

OP-EHEA210249 1..14

M. Leon, M. Valgimigli, A. Lansky, 2021 .

Advanced coronary artery disease: Appropriate end points for trials of novel therapies.

R. Califf, D. Mark, J. Jollis, 2001, American heart journal.

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials.

S. Saito, S. Windecker, D. Kandzari, 2021, American Heart Journal.

EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase.

E. Fearon, D. Kandzari, A. Heldman, 1996, Circulation research.

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

Malte Kelm, Ralph B D'Agostino, Jacek Kubica, 2015, Annals of internal medicine.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

N. Schork, P. Teirstein, M. Price, 2011, JAMA.

Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors.

D. Kandzari, P. Goldschmidt-Clermont, 2001, Journal of the American College of Cardiology.

An anomalous left coronary artery originating from the pulmonary artery in a 72-year-old woman: diagnosis by color flow myocardial blush and coronary arteriography.

D. Kandzari, V. Behar, J. K. Harrison, 2002, The Journal of invasive cardiology.

Evolution of Drug Development in Evidence-Based Medicine

R. Califf, D. Kandzari, D. Kong, 2003 .

Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.

B. Gersh, P. Serruys, G. Stone, 2019, The American journal of cardiology.

Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

W. Gibler, E. Ohman, Sidney C. Smith, 2005, The American journal of cardiology.

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

B. Gersh, P. Serruys, G. Stone, 2018, Journal of the American College of Cardiology.

Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.

V. Hasselblad, R. Califf, E. Topol, 2003, The American journal of cardiology.

Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.

Antonio Colombo, Takahiko Suzuki, Patrick W Serruys, 2005, Circulation.

Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II

Gary S. Mintz, Antonio Colombo, Jeffrey W. Moses, 2005, Circulation.

Epidemiology of Cardiovascular Disease and Refractory Angina

D. Kandzari, S. Lavi, G. Barsness, 2012 .

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

David B Matchar, Eric L Eisenstein, Robert M Califf, 2007, JAMA.

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Neil Chapman, Michael Böhm, Kazuomi Kario, 2017, The Lancet.

The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.

S. Pocock, K. Kario, M. Böhm, 2016, American heart journal.

MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury

P. Armstrong, R. Harrington, D. Kandzari, 2005, Expert opinion on investigational drugs.

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).

R. Califf, E. Topol, H. White, 2004, The American journal of cardiology.

Integrating Coronary Stents and Glycoprotein IIb/IIIa Inhibitors into a Mechanical Reperfusion Strategy

G. Stone, C. Grines, D. Kandzari, 2002 .

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2017, Journal of the American College of Cardiology.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease

P. Serruys, G. Stone, D. Kandzari, 2017 .

Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Elu

K. Anstrom, M. Leon, L. Mauri, 2009, JACC. Cardiovascular interventions.

Management of Percutaneous Coronary Intervention Complications

A. Kirtane, D. Kandzari, Robert F. Riley, 2020, Circulation. Cardiovascular interventions.

Stents: Safety and Efficacy

D. Kandzari, M. Eng, 2014 .

Midterm Outcomes from the TALON Registry: Treating Peripherals with SilverHawk: Outcomes Collection

C. Walker, D. Kandzari, R. Gammon, 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results

Antonio Colombo, Takahiko Suzuki, Patrick W Serruys, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

S. Hahn, Si‐Hyuck Kang, D. Kandzari, 2013, American heart journal.

Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome.

Sergio Berti, Malte Kelm, Marco Valgimigli, 2015, JACC. Cardiovascular interventions.

Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.

R. Schwartz, D. Kandzari, M. Sketch, 2003, American heart journal.

Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).

V. Hasselblad, M. Krucoff, W. Cantor, 2003, The American journal of cardiology.

Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.

S. Pocock, G. Stone, G. Dangas, 2008, Journal of the American College of Cardiology.

Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies

P. Teirstein, P. Serruys, G. Dangas, 2005 .

Coronary artery stents: Evaluating new designs for contemporary percutaneous intervention

James E Tcheng, D. Kandzari, J. Tcheng, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2015, Journal of the American Society of Hypertension : JASH.

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　- Insights From the SYMPLICITY HTN-3 Trial.

Deepak L. Bhatt, S. Oparil, K. Kario, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Clinical and angiographic correlates of left ventricular dysfunction in patients with three vessel coronary disease.

D. Kandzari, S. Qiao, Jin-qing Yuan, 2012, Chinese medical journal.

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis

P. Serruys, G. Stone, A. Kastrati, 2016, Circulation. Cardiovascular interventions.

Background—The safety and efficacy of new-generation drug-eluting stents (DES) in women with multiple atherothrombotic

P. Serruys, G. Stone, A. Kastrati, 2016 .

Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry

S. Garcia, A. Kirtane, F. Jaffer, 2016, Journal of the American Heart Association.

Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis

Sarabjeet Singh, R. Mehran, D. Kandzari, 2017, JAMA cardiology.

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Deepak L. Bhatt, S. Oparil, W. O’Neill, 2015, European heart journal.

Catheter-Based Renal Denervation Therapy: Evolution of Evidence and Future Directions

D. Kandzari, 2021, Circulation. Cardiovascular interventions.

Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation

D. Kandzari, H. Herrmann, Michael S. Lee, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

G. Chatellier, G. Parati, G. Grassi, 2020, European heart journal.

Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.

S. Pocock, P. Serruys, G. Stone, 2019, Journal of the American College of Cardiology.

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.

Renal Denervation: Past, Present, and Future

D. Kandzari, Ashkan Karimi, N. Pourafshar, 2016 .

Ready for a marathon, not a sprint: renal denervation therapy for treatment-resistant hypertension.

D. Kandzari, P. Sobotka, 2013, Journal of the American College of Cardiology.

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

G. Parati, T. Lüscher, C. Tsioufis, 2023, European heart journal.

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.

P. Fitzgerald, A. Kirtane, M. Leon, 2010, Journal of the American College of Cardiology.

Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

P. Fitzgerald, A. Kirtane, M. Leon, 2009, JACC. Cardiovascular interventions.

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

P. Fitzgerald, M. Leon, L. Mauri, 2006, Journal of the American College of Cardiology.

Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis

D. Kandzari, R. Shah, Samuel B. Latham, 2018, JAMA cardiology.

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

J. Massaro, L. Mauri, A. Roguin, 2017, The Lancet.

Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.

P. Serruys, G. Stone, A. Kastrati, 2016, JACC. Cardiovascular interventions.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

S. Windecker, J. Massaro, L. Mauri, 2015, JACC. Cardiovascular interventions.

Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials

P. Serruys, G. Stone, A. Kastrati, 2013, The Lancet.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

R. Whitbourn, P. Fitzgerald, A. Lansky, 2013, JACC. Cardiovascular interventions.

Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS CTO) Complications Score

S. Garcia, E. Mahmud, A. Kirtane, 2016, Journal of the American Heart Association.

Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents.

R. Kim, R. Judd, L. Shaw, 2006, Radiology.

DOES STUDY SUBJECT DIVERSITY INFLUENCE CARDIOLOGY RESEARCH SITE PERFORMANCE?: INSIGHTS FROM 2 U.S. NATIONAL CORONARY STENT REGISTRIES.

C. O'connor, R. Mehran, D. Kandzari, 2021, American heart journal.

Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).

J. Carroll, G. Stone, C. Grines, 2003, The American journal of cardiology.

Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

P. Teirstein, G. Stone, Seung‐Jung Park, 2009, Journal of the American College of Cardiology.

Regulation of the actin cytoskeleton by inositol phospholipid pathways.

J. Chen, D. Kandzari, P. Goldschmidt-Clermont, 1996, Sub-cellular biochemistry.

Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices

Samin K. Sharma, A. Kirtane, E. Brilakis, 2017, Expert review of medical devices.

A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.

M. Leon, D. Kandzari, J. Popma, 2009, The American journal of cardiology.

CRT-500.02 Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Three-Year Outcomes From the Randomized BIOFLOW V Trial

A. Roguin, D. Kandzari, D. Cutlip, 2018, JACC: Cardiovascular Interventions.

Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery.

J. Spertus, J. Moses, D. Kandzari, 2023, JACC. Cardiovascular interventions.

Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.

P. Serruys, G. Stone, F. Horkay, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From an International Multicenter Chronic Total Occlusion Registry

L. Stanberry, S. Garcia, E. Mahmud, 2019, Circulation. Cardiovascular interventions.

Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001.

L. Liao, D. Kandzari, B. Trichon, 2002, American heart journal.

Lifting the regulatory blanket off of covered stents.

D. Kandzari, S. V. Rao, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial

P. Serruys, G. Stone, M. Leon, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous intervention of circumflex chronic total occlusions is associated with worse procedural outcomes: insights from a Multicentre US Registry.

S. Garcia, A. Kotsia, B. Rangan, 2014, The Canadian journal of cardiology.

Seeking the optimal aspirin dose in acute coronary syndromes.

V. Hasselblad, R. Califf, L. Newby, 2002, The American journal of cardiology.

First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.

Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction

Deepak L. Bhatt, R. Perumal, D. Kandzari, 2016, Clinical cardiology.

Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.

M. Price, G. Stone, Z. Ali, 2022, JACC. Cardiovascular interventions.

G. Parati, T. Lüscher, C. Tsioufis, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.

G. Stone, W. O’Neill, M. Krucoff, 2022, American heart journal.

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

S. Saito, S. Windecker, D. Kandzari, 2021, Journal of the American Heart Association.

Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.

J. Moses, M. Leon, L. Mauri, 2010, JACC. Cardiovascular interventions.

Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents.

M. Leon, J. Massaro, L. Mauri, 2010, JACC. Cardiovascular interventions.

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension

R. Schmieder, D. Kandzari, A. Pathak, 2020, Journal of hypertension.

Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).

T. A. Stuckey, V. Hasselblad, R. Califf, 2004, The American journal of cardiology.

Contrast Nephropathy

D. Kandzari, M. Sketch, A. Rebeiz, 2003, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention.

S. Garcia, A. Kirtane, F. Jaffer, 2016, International journal of cardiology.

Percutaneous Treatment of Coronary Chronic Total Occlusion Part 2: Technical Approach.

E. Brilakis, I. Moussa, D. Kandzari, 2014, Interventional cardiology.

Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.

M. Leon, L. Mauri, D. Kandzari, 2013, JACC. Cardiovascular interventions.

The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.

S. Garcia, E. Mahmud, A. Kirtane, 2017, The Journal of invasive cardiology.

OUTCOMES WITH USE OF THE RETROGRADE APPROACH FOR CORONARY CHRONIC TOTAL OCCLUSION INTERVENTIONS IN A CONTEMPORARY MULTICENTER US REGISTRY

A. Kirtane, F. Jaffer, J. Moses, 2016 .

Contemporary Outcomes of the Retrograde Approach to Chronic Total Occlusion Interventions: Insights from an International CTO Registry.

S. Garcia, E. Mahmud, A. Kirtane, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry.

W. O’Neill, S. Garcia, E. Mahmud, 2018, The Journal of invasive cardiology.

Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial

K. Kario, M. Böhm, R. Townsend, 2020, Clinical Research in Cardiology.

Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies

Sarabjeet Singh, R. Mehran, D. Kandzari, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent.

M. Leon, D. Kandzari, 2006, Journal of interventional cardiology.

Development and performance of the zotarolimus-eluting Endeavor® coronary stent

D. Kandzari, 2010, Expert review of medical devices.

Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary

P. Fitzgerald, M. Leon, L. Mauri, 2011, JACC. Cardiovascular interventions.

Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.

S. Ellis, Marilyn Borgman, F. Resnic, 2007, The Journal of invasive cardiology.

Sex‐specific outcomes following revascularization with zotarolimus‐eluting stents: Comparison of angiographic and late‐term clinical results

M. Leon, L. Mauri, D. Kandzari, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian

S. Pocock, K. Kario, M. Böhm, 2020, Clinical Research in Cardiology.

Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials

S. Saito, S. Windecker, D. Kandzari, 2023, Clinical Research in Cardiology.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

A. Roguin, D. Kandzari, D. Cutlip, 2018, Journal of the American College of Cardiology.

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial.

Samin K. Sharma, P. Serruys, G. Stone, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials.

P. Teirstein, G. Stone, D. Kandzari, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Periprocedural Adverse Events After PCI and CABG on 5-Year Mortality: The EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2023, JACC. Cardiovascular interventions.

Outpatient Versus Inpatient Percutaneous Coronary Intervention in Patients with Left Main Disease (From the EXCEL Trial).

P. Serruys, G. Stone, D. Kandzari, 2020, The American journal of cardiology.

Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status.

B. Gersh, P. Serruys, G. Stone, 2020, The American journal of cardiology.

Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.

B. Gersh, P. Serruys, G. Stone, 2018, JACC. Cardiovascular interventions.

The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention.

E. Mahmud, A. Kirtane, F. Jaffer, 2017, The Journal of invasive cardiology.

TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

B. Gersh, S. Pocock, P. Serruys, 2018, Journal of the American College of Cardiology.

Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.

A. Roguin, D. Kandzari, D. Cutlip, 2020, JACC. Cardiovascular interventions.

Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus‐eluting coronary stent system using a Bayesian approach

J. Massaro, L. Mauri, D. Kandzari, 2017, American heart journal.

The Petal dedicated bifurcation stent.

D. Kandzari, J. Ormiston, M. Webster, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI.

P. Serruys, G. Stone, A. Kastrati, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

TCT-539 Impact of a Novel Advanced Robotic Wiring Algorithm on Time to Wire a Coronary Artery Bifurcation in a Porcine Model

Manish Parikh, Sunil V. Rao, J. Aaron Grantham, 2017 .

Comparison of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents and Thin, Durable-Polymer Everolimus-Eluting Stents in Calcified or Small Vessel Lesions

S. Saito, S. Windecker, D. Kandzari, 2020, Circulation. Cardiovascular interventions.

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.

P. Fitzgerald, D. Kandzari, Y. Honda, 2008, American heart journal.

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients: BIOFLOW V Acute Coronary Syndromes Subgroup

J. Massaro, A. Roguin, D. Kandzari, 2018, Circulation. Cardiovascular Interventions.

Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.

E. Mahmud, J. Tobis, D. Kandzari, 2010, The American journal of cardiology.

Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus.

S. Saito, S. Windecker, D. Kandzari, 2019, The American journal of cardiology.

Translational value of preclinical models for renal denervation: a histological comparison of human versus porcine renal nerve anatomy.

R. Virmani, A. Finn, D. Kandzari, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.

A. Roguin, D. Kandzari, D. Cutlip, 2022, JACC. Cardiovascular interventions.

Making positive out of negative trials.

D. Kandzari, P. Goldschmidt-Clermont, 2002, American heart journal.

A RANDOMIZED COMPARISON OF THE ENDEAVOR DRUG (ABT-578) ELUTING STENT VERSUS TAXUS PACLITAXEL-ELUTING STENT IN DIABETIC PATIENTS: THREE-YEAR OUTCOMES FROM ENDEAVOR IV

A. Kirtane, M. Leon, D. Kandzari, 2010 .

Use of Saphenous Vein Bypass Grafts for Retrograde Recanalization of Coronary Chronic Total Occlusions: Insights From a Multicenter Registry.

C. Ayers, B. Rangan, E. Brilakis, 2016, The Journal of invasive cardiology.

Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.

P. Blankestijn, R. Schmieder, D. Kandzari, 2021, American heart journal.

Comparison Between Traditional and Guide-Catheter Extension Reverse Controlled Antegrade Dissection and Retrograde Tracking: Insights From the PROGRESS-CTO Registry.

S. Garcia, E. Mahmud, A. Kirtane, 2019, The Journal of invasive cardiology.

Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).

Sarabjeet Singh, G. Dangas, D. Kandzari, 2023, The American journal of cardiology.

LATE-TERM SAFETY AND EFFICACY OUTCOMES FOLLOWING TREATMENT WITH ZOTAROLIMUS-ELUTING STENTS: 5-YEAR RESULTS OF THE POOLED ENDEAVOR TRIALS PROGRAM

M. Leon, L. Mauri, D. Kandzari, 2010 .

First report of a novel polymer‐free dual‐drug eluting stent in de novo coronary artery disease: Results of the first in human BICARE trial

D. Kandzari, Hongbing Yan, S. Qiao, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.

M. Price, G. Stone, S. Windecker, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

T. Henry, D. Kandzari, N. Kleiman, 2007, American heart journal.

Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease.

E. Brilakis, D. Kandzari, R. Shah, 2020, The American journal of cardiology.

Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes.

D. Kandzari, P. Smits, D. Cao, 2023, JACC. Cardiovascular interventions.

SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations

Jun Yu Li, R. Swaminathan, R. Townsend, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes.

A. Roguin, D. Kandzari, D. Cutlip, 2022, JACC. Cardiovascular interventions.

Ultrathin bioresorbable polymer sirolimus‐eluting stents in US patients undergoing coronary revascularization: 1‐Year outcomes from the BIOFLOW VII trial

S. Garcia, D. Kandzari, R. Stoler, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications.

T. Lüscher, D. Kandzari, W. Wijns, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

D. Kandzari, M. Morice, J. Sabik, 2020, The New England journal of medicine.

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.

Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.

B. Rangan, Subhash Banerjee, E. Brilakis, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.

P. Fitzgerald, A. Kirtane, M. Leon, 2010, Journal of the American College of Cardiology.

Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry).

E. Brilakis, D. Kandzari, D. Karmpaliotis, 2013, The American journal of cardiology.

TCT-308 Impact of Periprocedural Major Adverse Events After PCI and CABG on Long-Term Outcomes in Patients With Left Main Disease: The EXCEL Trial

P. Serruys, G. Stone, M. Leon, 2019, Journal of the American College of Cardiology.

Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.

D. Kandzari, M. Argenziano, A. Kirtane, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

R. Whitbourn, P. Fitzgerald, A. Lansky, 2013, JACC. Cardiovascular interventions.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

N. Schork, P. Teirstein, M. Price, 2011, JAMA.

Influence of Race/Ethnicity and Sex on Coronary Stent Outcomes in Diabetic Patients

Sarabjeet Singh, R. Mehran, D. Kandzari, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

P. Teirstein, D. Kandzari, D. Angiolillo, 2011 .

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

P. Pagé, D. Kandzari, M. Morice, 2018, Journal of the American College of Cardiology.

Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.

E. Mahmud, J. Tobis, D. Kandzari, 2010, The American journal of cardiology.

Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction

Deepak L. Bhatt, R. Perumal, D. Kandzari, 2016, Clinical cardiology.

Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.

D. Kandzari, M. Morice, J. Sabik, 2024, Journal of the American College of Cardiology.

Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial

E. Edelman, G. Stone, A. Íñiguez, 2017 .

A novel technique for ultra‐low contrast administration during angiography or intervention

Keshav R. Nayak, P. Teirstein, M. Price, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention.

G. Stone, Seung‐Jung Park, G. Biondi-Zoccai, 2010, JACC. Cardiovascular interventions.

Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction A Contemporary Review and Argument for Percutaneous Coronary Intervention

Seung‐Jung Park, G. Biondi-Zoccai, D. Kandzari, 2022 .

Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction A Contemporary Review and Argument for Percutaneous Coronary Intervention

Seung‐Jung Park, G. Biondi-Zoccai, D. Kandzari, 2022 .

FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT

M. Price, G. Stone, A. Kirtane, 2021 .

Drug-Coated Balloons for In-Stent Restenosis.

D. Kandzari, D. Kereiakes, J. Zidar, 2020, Journal of the American College of Cardiology.

Change we can believe in: the hyper-evolution of percutaneous coronary intervention for unprotected left main disease with drug-eluting stents.

P. Teirstein, M. Price, D. Kandzari, 2008, Circulation. Cardiovascular interventions.

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

P. Teirstein, M. Price, E. Topol, 2009, American heart journal.

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Deepak L. Bhatt, D. Kandzari, J. Davies, 2014, International journal of cardiology.